FDA Places Clinical Hold On Regenxbio's RGX-121 Following Asymptomatic Spine MRI Findings In Five CAMPSIITE Study Participants With Mucopolysaccharidosis Type II

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.